Sowing the seeds of doubt: a narrative review on metacognitive training in schizophrenia  by Moritz, Steffen et al.
Clinical Psychology Review 34 (2014) 358–366
Contents lists available at ScienceDirect
Clinical Psychology ReviewSowing the seeds of doubt: a narrative review on metacognitive training
in schizophreniaSteffen Moritz a,⁎, Christina Andreou a, Brooke C. Schneider a, Charlotte E. Wittekind a, Mahesh Menon b,c,
Ryan P. Balzan d, Todd S. Woodward b,c
a University Medical Center Hamburg-Eppendorf Department of Psychiatry and Psychotherapy, Martinistr. 52, D-20246 Hamburg, Germany
b Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
c BC Mental Health and Addictions Research Institute, Vancouver, BC, Canada
d School of Psychology, Flinders University, Adelaide, SA, Australia
H I G H L I G H T S
• Recovery under antipsychotics is incomplete.
• Dissemination of psychotherapy in psychosis is still poor.
• Metacognitive training (MCT) is available for free in 31 languages.
• MCT, particularly its individualized version, improves positive symptoms.⁎ Corresponding author. Tel.: +49 40 7410 56565; fax:
E-mail address:moritz@uke.uni-hamburg.de (S. Morit
http://dx.doi.org/10.1016/j.cpr.2014.04.004
0272-7358/© 2014 The Authors. Published by Elsevier Ltda b s t r a c ta r t i c l e i n f oArticle history:
Received 25 February 2014
Revised 22 April 2014
Accepted 29 April 2014
Available online 6 May 2014
Keywords:
schizophrenia
psychosis
metacognitive training
cognitive biases
delusions
paranoiaThe present article provides a narrative review of empirical studies on metacognitive training in psychosis
(MCT). MCT represents an amalgam of cognitive-behavioral therapy (CBT), cognitive remediation (CRT) and
psychoeducation. The intervention is available in either a group (MCT) or an individualized (MCT+) format.
By sowing the seeds of doubt in a playful and entertaining fashion, the program targets positive symptoms,
particularly delusions. It aims to raise patients’ awareness for common cognitive traps or biases (e.g., jumping
to conclusions, overconﬁdence in errors, bias against disconﬁrmatory evidence) that are implicated in the forma-
tion andmaintenance of psychosis. Themajority of studies conﬁrm thatMCTmeets its core aim, the reduction of
delusions. Problems (e.g., potential allegiance effects) and knowledge gaps (i.e., outcome predictors) are
highlighted. The preliminary data suggest that the individual MCT format is especially effective in addressing
symptoms, cognitive biases and insight. We conclude that MCT appears to be a worthwhile complement to
pharmacotherapy.
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Voltaire (French humanist 1694–1778)
1. Introduction
Delusions, commonly deﬁned as ﬁxed false beliefs that are held
with high conviction, are a hallmark feature of schizophrenia. Yet,
delusions are not pathognomonic of schizophrenia (Carpenter, Strauss,
& Muleh, 1973) and, in fact, represent a common transdiagnostic
symptom.
Conventionally, delusional beliefs are treated with antipsychotic
agents that act through a blockade of dopaminergic (mainly D2-
receptor mediated) neurotransmission. While the exact cognitive
pathways through which antipsychotics exert their effects have not
been fully unraveled, recent data suggest that antipsychotics promote
doubt (Andreou, Moritz, Veith, Veckenstedt, & Naber, 2014; Moritz,
Andreou, Klingberg, Thoering, & Peters, 2013; Moritz, Woodward,
Jelinek, & Klinge, 2008; Moritz, Woodward, & Ruff, 2003) and lead to
emotional detachment (Mizrahi et al., 2006). Despite their partial efﬁ-
cacy, discontinuation rates of antipsychotic medication are typically
quite high due to several factors such as lack of insight and adverse ef-
fects (Byerly, Nakonezny, & Lescouﬂair, 2007; Lambert et al., 2010;
Lieberman et al., 2005). Even when antipsychotics are taken as pre-
scribed, their effects on positive symptoms achieve only a moderate ef-
fect size (Leucht, Arbter, Engel, Kissling, & Davis, 2009), and complete
recovery is rare (Jaaskelainen et al., 2013).
Cognitive therapy for psychosis has attracted increasing attention in
recent years, based on two important trends. First, the initial enthusi-
asm for pharmacological monotherapy has been tempered by ﬁndings
signaling only partial efﬁcacy of antipsychotic medication, coupled
withmounting (but yet inconclusive) evidence of possible neurodegen-
erative effects of antipsychotic medications (Ho, Andreasen, Ziebell,
Pierson, & Magnotta, 2011; Moncrieff, 2011). Second, and perhaps
more importantly, cognitive researchers have begun to piece together
the basis of a psychological theory of psychosis, which has led to a num-
ber of fruitful heuristic models (Bentall et al., 2009; Freeman, 2007; van
der Gaag, 2006).
Psychological therapies use different approaches in treating delu-
sional beliefs and other symptoms of psychosis. Cognitive-behavioral
therapy (CBT) has gained the largest empirical support (Wykes, Steel,
Everitt, & Tarrier, 2008), despite recent criticism (Jauhar et al., 2014).
There is also evidence that cognitive remediation (CRT) ameliorates
cognitive dysfunction in schizophrenia (Wykes, Huddy, Cellard, McGurk,
& Czobor, 2011). Notwithstanding these improvements, the treatment
gap (i.e., absolute difference between the true prevalence of a disorder
and the treated proportion of individuals affected by the disorder) for
schizophrenia is estimated at 69% in most part of the world; that is,
only a minority of individuals with psychosis receive pharmacological
and/or psychological treatment (Lora et al., 2012). To bridge this gap
and “treat the untreated” low threshold programs are needed.
The remainder of this review will deal with metacognitive training
for psychosis (MCT) (Moritz, Veckenstedt, Bohn, Köther, & Woodward,
2013; Moritz, Vitzthum, Randjbar, Veckenstedt, & Woodward, 2010;
Moritz, Woodward, & Burlon, 2003, 2005). The intervention is available
either as a group (i.e., MCT) or an individualized (i.e., MCT+) format.
The manualized group training program (Moritz, Veckenstedt, Bohn,
Köther, et al., 2013; Moritz et al., 2010) is currently available at no
cost in 31 languages (free download at http://www.uke.de/mct).
MCT builds upon a large body of literature indicating that the corefeatures of delusions (such as overconﬁdence, incorrigibility and
hasty decision-making) are not conﬁned to delusional beliefs, but
rather represent more general biased styles of thinking that can be
observed in patients even in delusion-neutral situations. Importantly,
although these cognitive biases are implicated in psychosis, they are
viewed by cognitive psychology simply as an extension of normal
thinking styles, which can be addressed using standard psychological
approaches. Thus, delusions are perhaps only the visible “tip of the
iceberg.”
MCT can be considered an amalgam of CRT, CBT and psycho-
education. Like CRT, patients are presented with multiple cognitive
tasks (e.g., remembering details in a picture, deducing titles from paint-
ings), whereby the focus lies on attenuating overconﬁdence in errors
rather than accuracy. Like CBT for psychosis (CBTp), MCT shares the
goal of targeting psychotic symptoms, but adopts a “back door
approach” by dealing with cognitive processes ﬁrst and then pro-
ceeding to the symptom level (particularly the individualized variant
MCT+, see below). This more gentle approach is considered
advantageous for patients who cannot distance themselves from
their delusions or whose positive symptoms actually foster their self-
esteem (Moritz, Werner, & von Collani, 2006; Sundag, 2012) and are
considered by patients to be valuable (and partly positive) experiences
(Klapheck, Nordmeyer, Cronjager, Naber, & Bock, 2012). In accordance
with this, recent evidence shows that guided discovery, an effective
core technique of CBT, that uncovers incongruities or inconsistencies
in patients’ conclusions, may reduce the therapeutic alliance (Wittorf
et al., 2013). Table 1 summarizes the content and learning aims of the
eight MCT group modules.
MCT+ is the individualized format of MCT, which is available for
free in seven languages via www.uke.de/mct_plus. Over and above
the domains addressed in MCT, it targets negative symptoms and
allows for in-depth assessment and treatment of individual symp-
toms through the generation of an illness model and a recovery plan.
1.1. Metacognitive training in schizophrenia (MCT)
The training (2 sets of 8 modules each for most language versions)
capitalizes on the ﬁnding that patients display increased cognitive
biases, which according to recent reviews, are putatively involved in
the formation and maintenance of psychosis (e.g., Garety & Freeman,
2013; Moritz, Andreou, et al., 2013; Moritz, Veckenstedt, Bohn,
Hottenrott, et al., 2013; Moritz, Veckenstedt, Bohn, Köther, et al.,
2013). Importantly, patients are often unaware of these biases as well
as cognitive impairments (Freeman, 2007; Moritz, Ferahli, & Naber,
2004). Heuristic models like the one proposed by Freeman (2007) as-
cribe both emotional and cognitive factors an important role in the
pathogenesis of psychoses. Affective states, particularly depression
and anxiety, are regarded as necessary but not sufﬁcient preconditions.
If these coincidewith anomalous experiences and/or reasoning biases, a
psychotic episode may occur.
Beta versions of the training date back to 2002; the modules ad-
dress all cognitive biases highlighted in a review by Garety and Free-
man in 1999: jumping to conclusions (Garety & Freeman, 2013;
Garety, Hemsley, & Wessely, 1991; Lincoln, Ziegler, Mehl, & Rief,
2010), impairments in social cognition/theory of mind (Brüne, 2005;
Roder & Medalia, 2010; Savla, Vella, Armstrong, Penn, & Twamley,
2013), attributional distortions (Bentall, Corcoran, Howard, Blackwood,
& Kinderman, 2001; Kinderman & Bentall, 1997; Randjbar, Veckenstedt,
Vitzthum, Hottenrott, & Moritz, 2011) and affective biases (Freeman
et al., 1998; Moritz et al., 2006). Moreover, the training incorporates
Table 1
Content and learning aims of the eight MCT group modules.
MCT module Exercises (examples) Learning aim
1. Attribution [Mono-causal inferences] Different causes (self, others, circumstances) for
complex positive and negative events must be
contemplated (e.g., you fail an exam).
Patients are taught to consider various causes instead of
converging on mono-causal explanations. The negative
consequences of a self-serving attribution are highlighted.
2. Jumping to conclusions I Fragmented pictures are shown that eventually
depict objects. Hasty decisions often lead to errors
and new evidence discourages certain
alternatives.
The disadvantage of jumping to conclusions is stressed.
3. Changing beliefs [Bias against disconﬁrmatory evidence] Cartoon sequences are shown in backward order,
which increasingly disambiguate a complex
scenario. After each (new) picture, the plausibility
of four interpretations has to be re-rated. On some
pictures, patients are ‘led up the garden path’.
Patients learn to withhold strong judgments until sufﬁcient
evidence has been collected, and to consider counter-arguments
and alternative views.
4. To empathize I Pictures of human faces are presented. The group
should guess what the depicted character(s) may
feel. The correct solution often violates a ﬁrst
intuition.
It is demonstrated that facial expressions can be misleading for
social decision-making and that response conﬁdence needs to
be attenuated in case of scarce evidence.
5. Memory [Over-conﬁdence in errors] Complex scenes (e.g. beach) are displayed
prompting high-conﬁdent false memories for
typical items (e.g. memorizing a ball although it
has not been presented).
The constructive nature of memory is emphasized. Patients are
encouraged to decrease conﬁdence when evidence is lacking.
6. To empathize II [Theory of mind second order] The perspective of one protagonist must be
considered, which involves discounting
knowledge available to the observer but not
available to the protagonist.
Patients are taught that social situations often lack a clear-cut
solution and that multiple pieces of evidence have to be
contemplated before a deﬁnite decision can be reached.
7. Jumping to conclusions II Paintings are displayed, for which the correct title
must be deduced from four response options.
Many pictures elicit false responses.
The disadvantages of hasty decision making are emphasized.
8. Mood and self-esteem Typical depressive cognitive patterns are
presented (e.g. over-generalization), and the
group is asked to come upwithmore constructive
and positive ones.
Strategies for raising andmaintaining self-esteem are conveyed.
360 S. Moritz et al. / Clinical Psychology Review 34 (2014) 358–366biases proposed by MCT’s developers: over-conﬁdence in errors
(Moritz & Woodward, 2006; Moritz et al., 2008) and a bias against
disconﬁrmatory evidence (Sanford, Veckenstedt, Moritz, Balzan, &
Woodward, 2014; Woodward, Buchy, Moritz, & Liotti, 2007;
Woodward, Moritz, Menon, & Klinge 2008).
As presented in more detail in the manual, MCT and MCT+ target
patients with positive symptoms. It is advised that patients either dis-
play delusional symptoms currently or have displayed these symptoms
in the past. As group settings can be disrupted by behavioral distur-
bances, patients with very severe forms of delusions, formal thought
disorder and hostility should refrain from participating in MCT until
some remission has taken place. Here, MCT+ or individualized CBT
may be offered to the patient instead.
In short, MCT aims to sow the seeds of doubt through corrective
(“aha!”) experiences in an entertaining, playful and collaborative man-
ner. By presenting predominantly neutral (non-delusional) scenarios,
MCT aims to shake (some of) the cognitive foundations of delusions,
which is hoped to ultimately lead to the crumbling of delusional con-
viction. Cognitive biases, particularly jumping to conclusions and
overconﬁdence, are regarded as basic driving mechanisms that turn
(initially) benign false judgments into perpetuated delusional
systems. The various modules of MCT demonstrate to patients that
complex events can have very different explanations and are rarely
determined by single causes (modules 1 and 6), that evidence can
change over time (module 3) and that one should not jump to conclu-
sions or be too conﬁdent in judgments, particularly in situations with
potentially momentous outcomes (modules 2, 4, 5, 7). This is achieved
by a dialectic approach. On the one hand, eachmodule aims to normal-
ize these cognitive biases to some degree by running through everyday
examples that demonstrate the fallibility of human cognition per se.
This is an important feature because it has been demonstrated that nor-
malization and reduction of stigma can foster treatment engagement
for psychotherapy (Lullmann & Lincoln, 2013). However, it is also
brought to the patient’s attention that these cognitive biases are exag-
gerated in many patients, potentially creating problems in socialinteraction, and possibly contributing to psychotic symptoms. Thus,
the intervention aims to make the causes/origins of psychotic symp-
toms more understandable instead of demonizing them, thereby
possibly reducing stigma and increasing hope and self-efﬁcacy. We
propose that MCT may reduce delusions by training patients to be
less conﬁdent in their judgments and to seek more evidence. For
most language versions, two parallel cycles exist.
The aimof the present article is to provide a narrative reviewof stud-
ies conducted on MCT and its variants.
2. Methods
This narrative review is based on the literature that came to our
attention on or before December 31st, 2013. We took several ap-
proaches to compiling literature for this review. First, as the two
main developers of MCT are authors on this review, we were in-
formed by the ﬁrst authors of most studies upon completion of
their trials. In addition, we asked individuals who translated MCT
about research activities in their countries. Finally, we searched sci-
entiﬁc databases (i.e., MEDLINE/pubmed.com, PsycLit and Psyndex)
with the following terms: (psychosis or psychotic or schizophren*)
and (metacogn* or reason* or “cognitive bias*”) and (training or
therap*); however, this yielded no new ﬁndings relevant to the pres-
ent review. Studies conducted on metacognitive therapy (MCT) by
Adrian Wells, a generic and very different concept despite a similar
name, were not considered. We included both controlled and uncon-
trolled trials, whereby only the former studies receive special weight
and are summarized in Table 2.
3. Results
3.1. Studies on MCT
A number of mostly small to medium-sized studies have investigat-
ed the acceptance and efﬁcacy of metacognitive training. All completed
Table 2
Studies on MCT for psychosis.
Authors Sample RCT Diagnosis,
in- or out-
patient
program
Format blinded Measurement Effect on
positive
symptoms
[0, (+),
+]
Effect on
objective
biases [0,
(+), +]
Effect on
subjective
biases [0,
(+), +]
Subjective
appraisal
[0, (+),
+]
Main ﬁndings and limitations
Group training
Moritz &Woodward, 2007 (*) N = 40; MCT vs.
(CogPack)
yes Sz spectrum
outpatients
group subjective
assessment
only
retrospective
assessment
after four
weeks
n.a. n.a. n.a. + MCT N control on 4 out of 10 subjective parameters (e.g., less
boring, fun, useful to daily routine). Study did not address
efﬁcacy.
Aghotor et al., 2010 (*) N = 30; MCT versus
active control (discussion
of articles)
yes Sz spectrum
inpatients
group yes baseline, four
weeks
(+) (+) n.a. + No signiﬁcant group effects. Weak-to-medium
effects in favor of MCT for JTC, positive symptoms and medi-
um effects for subjective training success. Underpowered
trial; active control condition
received lower treatment dosage
Kumar et al., 2010 N = 16; MCT (adapted to
cultural differences) vs.
TAU
yes paranoid Sz
inpatients
group yes baseline, after
two and four
weeks
(+) n.a. n.a. n.a. MCT N control on conceptual disorganization and tension.
Medium-to-large effect sizes on PANSS positive scale and
BABS subscales (but n.s.). underpowered trial
Moritz, Kerstan, et al., 2011
(*)
N = 36; MCT versus
wait-list
yes Sz spectrum
in- or out-
patients
group yes baseline, end of
training
(≈8 weeks)
(+) (+) n.a. + MCT N control for delusion distress, memory and social
quality of life. No differences occurred on the PANSS. Data
gathering improved at amedium effect size. 100% completion
rate, mainly chronic patients, approx. half fulﬁlled criteria for
substance abuse or dependence
Naughton et al., 2012 N = 27; MCT versus
wait-list
no mainly Sz
patients,
from
forensic
mental
hospital
group no 9/2009 prior to
treatment, 3/
2010 after
treatment
(+) n.a. n.a. n.a. MCT N control on capacity to consent to treatment
(correlated with the number of sessions attended) and GAF
scores. No changes on PANSS. Authors acknowledge non-RCT
design and small sample as limitation. Three did not meet
criteria for schizophrenia.
Moritz, Veckenstedt, Bohn,
Hottenrott, et al., 2013;
Moritz, Veckenstedt, Bohn,
Köther, et al., 2013; Moritz
et al., 2014 (*)
N = 150; MCT vs.
CogPack
yes Sz spectrum
in- or out-
patients
group yes baseline, after
one cycle
(≈four weeks),
six months,
three years
+ 0 n.a. + MCT N control on PANSS delusion subscore
(primary outcome; follow-up), positive score (post-treat-
ment) and PSYRATS delusion score (post-treatment and
follow-up). Improvement on PANSS positive scale at post and
follow-up positively correlatedwith number of attendedMCT
sessions. No changes seen for other
psychopathological syndromes.
After three years, “sleeper effects”: MCT N control on self-
esteem, PANSS total score and quality of life. MCT N control
for PSYRATS delusions and PANSS positive syndrome. No
signiﬁcant differences on JTC
Kuokkanen et al., 2014 N = 20; MCT versus TAU yes Sz
inpatients
with a
history of
violence
group yes baseline,
4 weeks,
3 months,
6 months
+ - n.a. n.a. MCT N control on PANSS suspiciousness, largest difference at
3 months. By the 6-month follow-up, difference declined but
still signiﬁcant. No signiﬁcant improvement in reasoning ability
was achieved. Only a small male sample was examined.
Favrod et al., 2014 (*) N = 52; MCT versus TAU yes Sz spectrum
outpatients
group yes baseline,
8 weeks,
6 months
+ n.a. n.a. n.a. MCT N TAU on PANSS positive, PSYRATS and SUMD aware-
ness of delusions (medium-to-strong effect size for both post
and follow-up). For hallucinators, similar results on PSYRATS
hallucinations subscale
Lam et al., 2014 N = 80; MCT vs TAU yes Sz spectrum
in- or
outpatients
group self-report
scale
baseline, after
training
(4 weeks alter)
n.a. n.a. + + MCT N TAU on BCIS self-reﬂectiveness and total score as well
as general self-efﬁcacy (large effect size). No symptoms were
assessed.
(continued on next page)
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Table 2 (continued)
Authors Sample RCT Diagnosis,
in- or out-
patient
program
Format blinded Measurement Effect on
positive
symptoms
[0, (+),
+]
Effect on
objective
biases [0,
(+), +]
Effect on
subjective
biases [0,
(+), +]
Subjective
appraisal
[0, (+),
+]
Main ﬁndings and limitations
van Oosterhout et al., 2014 (*) N = 154; MCT vs. TAU yes Sz spectrum
patients
group yes baseline, after
8 weeks, after
24 weeks
0 n.a. 0 n.a. Decrease in symptoms for both groups. MCT not superior to
control on delusions (PSYRATS, GPTS), cognitive insight,
cognitive biases and health care costs. All patients displayed
at least for moderate-to-severe delusional symptoms as
assessed by GPTS which may have compromised compre-
hension. State of the art methodology was adopted.
Briki et al., 2014 N = 50 (analyzed), MCT
versus Supportive Therapy
(ST)
yes Sz spectrum
in- or out-
patients
group yes baseline, after
8 weeks
(+) n.a. n.a. (+) MCT N ST on PANSS positive syndrome, trend in favor of MCT
for insight on hallucinations and social functioning
Individualized training or blended versions
Moritz, Veckenstedt,
Randjbar, Vitzthum, &
Woodward, 2011 (*)
N = 48; MCT/
MCT+ versus CogPack
yes Sz
inpatients
individual
(MCT+)
and
group
(MCT)
yes baseline, four
weeks
+ + n.a. + MCT N control for PANSS delusion subscore and
2/3 positive scores, JTC, PSYRATS delusions
conviction (medium-to-strong effect); no effect on total
score. Weak-to-medium effect for PSYRATS; excellent sub-
jective appraisal. Trial tested beta version of MCT+.
Ross et al., 2011 N = 34; single session
Reasoning Training versus
active control
yes Sz
spectrum;
in- or out-
patients
individual no before, after
training
(+) (+) n.a. n.a. Data-gathering but not JTC improved in reasoning group; less
conviction and belief ﬂexibility in
reasoning group after training. Routine scales like PANSS
were not administered.
Rocha & Queirós, 2013 N = 35; MCST
(MCT+ SCIT; 18 sessions)
versus TAU
non-
random
allocation
Sz
outpatients
group unclear baseline, after
training
(10 weeks
program)
0 + n.a. n.a. MCST N TAU for JTC and some measures of ToM, social per-
ception, functional outcome and emotion recognition. Trend
for general symptoms. No
effects on positive and negative symptoms. Trial cannot tease
apart contribution of MCT versus
social cognition training.
Balzan et al., in press (*) N = 28; MCT single
session (exercises
modules 2,3 and 7) versus
wait-list
no Sz
outpatients
individual no baseline,
2 weeks after
treatment
+ + (+) + MCT N control on positive symptoms (PANSS, SAPS, PDI),
including delusional severity and conviction as well as QoL
and cognitive bias
performance. Insight ameliorated for SAI but not BCIS. Patients
were on antipsychotic medication for least 12 months
Erawati, in press N = 56; MCT versus TAU no Sz spectrum
inpatients
individual no baseline, after
four weeks
+ n.a. + + MCT N TAU on PSYRATS delusion subscale and self-devised
metacognition self-report scale (MAQ) at a very large effect
size. Excellent adherence and subjective appraisal. Group
MCT slides used for individual administration;
allocation to treatment based on patient’s
preference. Non-RCT trial.
(0 = no support; (+) = partial support; + (predominant) support.)
BAPS = Brown Assessment of Beliefs Scale; CBQp = Cognitive Biases Questionnaire for Psychosis; GPTS = Green Paranoid Thoughts Scale; JTC = jumping to conclusions; PDI = Peters et al. Delusions Inventory, QoL = quality of life;
SAI = schedule for assessing insight; SAPS = Scale for the Assessment of Positive Symptoms, SUMD = Scale to Assess Unawareness in Mental Disorder; SZ = schizophrenia; TAU = treatment as usual; ToM = theory of mind.
(*) = study planned, conducted and/or published with the help of at least one of the main developers.
Nsigniﬁcant difference.
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lished studies, are summarized in Table 2.Most of these studies have ex-
amined the standard group training. Some assessed abbreviated MCT
versions, mixed therapy programs that blended MCT with other ap-
proaches, or individualized versions of MCT (either the individualized
metacognitive therapy programMCT+ or group MCTmodules tailored
to the needs of individual patients). The next sections will focus on the
acceptability of the intervention, and its effectiveness on positive symp-
toms and cognitive biases. Other domains either are beyond the scope of
the training (e.g., negative symptoms) or have been addressed by too
few studies to allow clear-cut inferences.
3.2. Safety and acceptance
Following a feasibility trial (Moritz & Woodward, 2007) conducted
in Hamburg (Germany), several (subsequent) studies have asserted
the safety and acceptance of MCT. All of the studies that assessed
patients’ appraisals (mainly with the 10-item questionnaire used
in the initial study) showed that MCT is well received by patients
(Aghotor, Pfueller, Moritz, Weisbrod, & Roesch-Ely, 2010; Balzan,
Delfabbro, Galletly, & Woodward, in press; Briki et al., 2014; Erawati, in
press; Favrod, Maire, Bardy, Pernier, & Bonsack, 2011; Favrod et al.,
2014; Ferwerda, de Boer, & van der Gaag, 2010; Lam et al., 2014; Moritz,
Kerstan, et al., 2011; Moritz, Veckenstedt, Bohn, Hottenrott, et al., 2013;
Moritz, Veckenstedt, Randjbar, Vitzthum, &Woodward, 2011). The inter-
vention is considered to be fun by at least three out of four patients and
participants would recommend it to other individuals with schizo-
phrenia. Although enjoyment and subjective beneﬁt are secondary
outcome parameters, we deem them important prerequisites in
view of the frequent avolition, poor motivation and affective ﬂat-
tening in the target population that are risk factors for non-
adherence. However, one limitation is that not all patients with
schizophrenia display all cognitive biases addressed in MCT and,
as such, it may be that not all modules are equally relevant for all
group members.
3.3. Delusions and positive symptoms
Table 2 shows that except for one important exception (van
Oosterhout et al., 2014) discussed below, most studies report that
MCT improves symptoms. The magnitude of change observed ranged
from small (Aghotor et al., 2010) and medium (Briki et al., 2014;
Favrod et al., 2014; Gawęda, Krężołek, Olbryś, Turska, & Kokoszka,
2014; Kumar et al., 2010; Kuokkanen, Lappalainen, Repo-Tiihonen, &
Tiihonen, 2014;Moritz, Veckenstedt, Bohn, Hottenrott, et al., 2013;Mo-
ritz, Veckenstedt, et al., 2011) to large effect sizes (Balzan et al., in press;
Erawati, in press) with respect to MCT’s effects on positive symptoms.
Also, uncontrolled trials found strong effects on positive symptoms
(Favrod et al., 2011). Factors contributing to differences in effect sizes
include between-studydifferences in the primary outcomemeasure. Ef-
fects on delusion severity or other delusion dimensions (Moritz,
Kerstan, et al., 2011) as assessed with the PSYRATS (Haddock,
McCarron, Tarrier, & Faragher, 1999) and/or PANSS (Kay, Opler, &
Lindenmayer, 1989) tended to be larger. While some studies report im-
provement on both scales (Favrod et al., 2014; Ferwerda et al., 2010), in
others, the PSYRATS was more sensitive than the PANSS (Moritz,
Kerstan, et al., 2011; Moritz, Veckenstedt, Bohn, Hottenrott, et al.,
2013), and in two studies, the opposite was true (Briki et al., 2014;
Moritz, Veckenstedt, et al., 2011). These discrepancies might be attrib-
utable to subtle differences between the two rating scales. The
PSYRATS is more ﬁne-grained and distinguishes different aspects of de-
lusions and hallucinations (such as conviction and distress) that are
pooled in PANSS items P1 (delusions) and P3 (hallucinations). How-
ever, patients sometimes underreport symptoms at baseline because
of lack of insight and mistrust, causing real improvement to falsely
manifest as objective decline. The PSYRATS is perhaps more proneto such errors than the PANSS as it more heavily relies on self-
report. Further controlled studies that use uniform outcome mea-
sures are needed to clarify MCT’s impact on positive symptoms and
to determine effect size.
The abovementioned studies investigated the short-term efﬁcacy of
MCT, assessing changes in symptoms and cognitive biases immediately
upon completion of the intervention. Two trials (Favrod et al., 2014;
Moritz, Veckenstedt, Bohn, Hottenrott, et al., 2013) also speak for the
long-term efﬁcacy of MCT, up to six months after the intervention. The
latter trial detected “sleeper effects” three years after the intervention:
the PANSS total score (as well as quality of life subscores and self-
esteem) distinguished MCT participants from the active control group,
while there were no differences in these outcome parameters between
the two interventions at prior assessment points (Moritz et al., 2014).
Positive effects on symptoms have also been found with similar
programs (Ross, Freeman, Dunn, & Garety, 2011), such as the Maudsley
Review Training Program (Waller, Freeman, Jolley, Dunn, & Garety,
2011), a computerized training package with ﬁve tasks relating to JTC,
where two of these tasks are similar to module 2 of MCT (one task set
was directly taken from module, the other from the Ross et al. study,
which was later incorporated into MCT). A Portuguese study (Rocha &
Queirós, 2013) blended MCT with Social Cognition and Interaction
Training (SCIT; Combs et al., 2007) and found some improvements in
general but not positive symptoms.
A Dutch trial (van Oosterhout et al., 2014) showed no advantage of
MCT over TAU on any outcome measure. Also, improvements for the
MCTgroupwere smaller, particularly for the PSYRATSdelusion (3.5 ver-
sus 1.6 points improvements) and GPTS total score (16.9 versus 14.7
points improvement), than in the forerunner trial conducted by the
same group (Ferwerda et al., 2010). As can be seen in Table 2, the trial
by vanOosterhout et al. recruited a large sample and used an earlier ver-
sion of MCT (later versions place more emphasis on the importance of
doubt for decision-making, and encourage participants to revise their
judgment if evidence is weak and consequences are momentous). One
possible limitation of this study is that the primary outcome was a
self-report scale. Underreporting of symptoms is common in patients
prior to therapy, mainly because of mistrust, poverty of speech and
lack of illness insight. As these confounds decline over time, this may
lead to the paradoxical effect of an apparent increase of symptom sever-
ity when in fact symptoms have improved. More importantly, the study
only included subjects with medium or high delusion levels. Although
at ﬁrst glance this appears reasonable for a training aimed at improving
delusions, from a clinical standpoint and in our experience, it is prob-
lematic for a group setting as participants are often easily distracted,
or disturb other members by making inappropriate comments. Accord-
ingly, we recommend that patients should start the training only once
sufﬁcient clinical stability is reached.
3.4. Cognitive biases
Most trials investigating the impact of MCT on cognitive biases
focused on the jumping to conclusion bias. As Table 2 shows, some
(Aghotor et al., 2010; Balzan et al., in press; Ferwerda et al., 2010;
Moritz, Kerstan, et al., 2011; Moritz, Veckenstedt, et al., 2011; Ross et al.,
2011; Waller et al., 2011), but not all, studies (Gawęda et al., 2014;
Kuokkanen et al., 2014; Moritz, Veckenstedt, Bohn, Hottenrott, et al.,
2013) found that MCT or variants of it improve data gathering or
jumping to conclusions at least at a weak-to-moderate effect size.
Data by Köther et al. (submitted), which was derived from another
trial (Moritz, Veckenstedt, Bohn, Hottenrott, et al., 2013), reported
that overconﬁdence in errors was ameliorated to a larger extent in the
MCT relative to the CRT group after sixmonths of treatment. Positive ef-
fects of MCT were also detected for the representativeness and illusion
of control biases (Balzan et al., 2014). Evidence from three trials tenta-
tively suggests that individualized training versus group training may
be more effective at correcting this rather deep-rooted bias (Balzan
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work is needed to examine if biases other than JTC are affected by MCT
interventions.
Cognitive insight or metacognition has been captured with different
instruments, for example the Beck Cognitive Insight Scale (BCIS), which
showed improvements in some (Erawati, in press; Ferwerda et al.,
2010; Gawęda et al., 2014; Lam et al., 2014) but not all trials (van
Oosterhout et al., 2014). One trial found greater improvement in clinical
but not cognitive insight (Balzan et al., 2014). An Indonesian study
(Erawati, 2014) yielded very large effects using the self-devised
Metacognitive Abilities Questionnaire (MAQ), whereby it must be
noted that no RCT design was adopted in this trial.
3.5. Limitations
Table 1 shows that for some trials, the developers of the interven-
tion either conducted the studies or were otherwise involved. De-
spite blinded assessment in most trials, allegiance effects cannot be
fully ruled out, although positive effects of similar magnitude were
reported by studies that were planned, carried out and published
without the involvement of the developers or team members (e.g.
Erawati, 2014).
We chose to compile the existing data on MCT by means of a narra-
tive review rather than ameta-analysis as studies differed across essen-
tial parameters, most importantly outcomemeasures (PSYRATS, PANSS
positive or adapted scores) and the variations administered (the exact
edition of group MCT used is often not stated; shortened and blended
versus full versions; MCT performed in groups versus individually).
Some studies – including our own –face the problem that overlapping
outcome parameters were adopted (e.g., PANSS versus PSYRATS),
which do not always yield consistent results. Although multiple mea-
sures capturing the same outcome could be considered a limitation of
previous studies, it is a necessity when assessing the efﬁcacy of a new
treatment, as little is yet known about mechanisms of action. At this
stage, the use of these overlappingmeasures tapping objective and sub-
jective cognitive biases allows us to better understand the mechanisms
through which MCT might ameliorate delusions. One virtue of MCT is
that it is free to download and available in a variety of languages,
which has fostered its dissemination; however, this also creates obvious
problemswith regard tomethodological rigor. Trials were administered
by therapists from different professions including occupational thera-
pists (Lam et al., 2014), nurses (Erawati, 2014; Favrod et al., 2011,
2014) and psychologists (Moritz, Kerstan, et al., 2011; Moritz,
Veckenstedt, Bohn, Hottenrott, et al., 2013; Moritz, Veckenstedt, et al.,
2011). Few therapists were trained by the developers of MCT, and
there is no formal training curriculum. Therefore, the degree of adher-
ence to the manual is unknown. However, even studies without such
standardized protocols reported positive results. As standardization of
therapy administration and treatment experience will likely increase
the efﬁcacy of the treatment for future trials, we aim to provide a curric-
ulum for trainers to teach them the basics of MCT ﬁrst hand for the
future.
A further problem relates to the narrow scope of the training, asMCT
addresses only positive symptoms. To achieve comprehensive treat-
ment success, therapists are advised to blend MCT with other proce-
dures that successfully target negative symptoms, disorganization,
social and cognitive impairment. While negative symptoms are not dis-
order speciﬁc, these are the symptoms patients suffer from most
(Rosenheck et al., 2005). A newer version of the MCT group training
(edition 5.0) as well as MCT+ incorporate novel exercises dealing, for
example, with social problems (e.g., group rules are posted during
each session that teach patients to be considerate about other people’s
opinions and to avoid monologues), and exercises should be tailored
more to individual problems in order to involve patients with compre-
hension difﬁculties; MCT+ directly addresses problems with volition
and other negative symptoms. Notwithstanding these efforts, the effectof these changes has not yet been established. Finally, we need to know
more about differential indicators, that is, who beneﬁts from training
and who does not.
3.6. Conclusions and future directions
So far, the evidence for MCT is encouraging, but remains prelimi-
nary. Table 2 shows that most studies provided support for the efﬁ-
cacy of MCT for the treatment of positive symptoms, as well as the
amelioration of objective and subjective cognitive biases. Studies,
particularly those using the new and improved versions of MCT
andMCT+, conﬁrm that the intervention exerts a (close to) medium
effect size on positive symptoms over and above the effect of anti-
psychotic medication.
Currently, we are working on identifying neural regions that are
affected by MCT, and if MCT/MCT+ ameliorates positive symptoms in
patients who are either resistant to antipsychotics and/or reject taking
antipsychotic medication. Trials have also begun to blend MCT with
other programs, such as SCIT (see Rocha & Queirós, 2013). Colleagues
have also started to add additional modules to the 8-module package,
for example on trust and cognitive biases (Balzan et al., 2014). We
fully endorse such hybrid packages. In our experience, group MCT
may also facilitate the administration of CBT, as it provides a theoretical
framework and shared terminology that the therapist and patient can
refer to.We have now begun to expand theMCT concept to other disor-
ders (e.g., http://www.uke.de/mymct; http://www.uke.de/borderline).
As some biases, particularly attributional biases and negative cognitive
schemata, are transdiagnostic, some overlap exists among the different
treatments.
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